… showed YKL-40 expression in the malignant tumor cells. In conclusion, serum YKL-40 was
… referred to as squamous cell carcinomas of the head and neck (HNSCC), are common types …

… Patients with stage 1 disease had lower, but non-significant, serum YKL-40 compared to …
serum YKL-40 had significantly shorter survival than patients with normal serum YKL-40 (33 …

… A total of 13 studies have demonstrated that elevated serum YKL-40 in patients with breast,
colorectal, head and neck, renal cell, prostate, ovarian and small cell lung cancer, malignant …

… elevated plasma YKL-40 is defined as an age-corrected plasma YKL-40 concentration
higher than the 95 th or the 97 th percentile of plasma YKL-40 in healthy age-matched subjects. …

… YKL-40 plays a role in proliferation and differentiation of malignant cells. The aim of this study
was to examine whether YKL-40 … The tissue expression of YKL-40 was assessed using an …

… YKL-40 was significantly associated with poor OS (HR, 1.44; 95% CI 1.33–1.56). We also
found that elevated serum/plasma YKL-40 … effect of serum/plasma YKL-40 was not statistically …

… YKL-40 levels have been associated with a poor prognosis.15, 22, 25-36 Serum YKL-40 was
a … who had lower serum YKL-40 levels and suggested the use of YKL-40 as a biomarker for …

… These findings are novel in the ASC setting but in line with data reported in head and neck
and … In particular, high serum YKL-40 identifies a subgroup of patients with head and neck …

… YKL-40 was positive in both our cases, both in parental and … YKL-40 expression associated
with the lack of EGFR … However, we describe two metastasizing GBM that labeled for YKL-40, …

… demonstrated elevated YKL-40 serum levels in cancer patients and found YKL-40 to be
correlated with a poor prognosis and disease severity in some tumor entities. YKL-40 was …